DeepIntent Vistar DOOH integration unifies pharma ads across streaming and billboards

This integration addresses the historical targeting and measurement gaps that have kept pharmaceutical budgets away from digital out-of-home media. By consolidating outdoor screens into a vertical DSP, agencies can now reallocate budgets between streaming video and physical displays based on real-time performance signals rather than managing separate, static buys. This move signals a shift where place-based healthcare media is treated as a standard programmatic line item rather than a niche specialty. As the industry moves forward, watch for whether DeepIntent can provide the same level of audited measurement for broadcast DOOH impressions that the Media Rating Council now requires for point-of-care digital advertising.

DeepIntent's integration with Vistar Media arrives at a pivotal moment for the DOOH supply side. In January 2025, T-Mobile announced plans to acquire Vistar Media for approximately $600 million in cash, signaling that the carrier sees programmatic out-of-home as a core growth vertical rather than an experimental bet. T-Mobile's advertising unit now combines Vistar's SSP technology with its own first-party mobile network data, enabling audience segments built from app ownership and device-level location signals that can be activated across physical screens. For DeepIntent, this means the Vistar inventory it now accesses sits within a telco-owned ecosystem that is actively building data-driven targeting capabilities, potentially enriching the patient-audience matching that underpins DeepIntent's healthcare DSP.

The broader telco ad tech landscape provides important context for this partnership's strategic positioning. AdExchanger reported in December 2025 that T-Mobile has defied the pattern of telcos acquiring and then divesting ad tech assets, unlike AT&T's sale of Xandr to Microsoft or Verizon's offloading of its AOL and Yahoo media business to Apollo Funds. T-Mobile's continued investment, which includes the earlier acquisitions of rideshare ad network Octopus Interactive and location data platform Blis, suggests Vistar's infrastructure will remain a stable supply source for DSP partners like DeepIntent. Meanwhile, The Trade Desk acquired metadata company Sincera in the same week as the T-Mobile-Vistar deal, underscoring that consolidation across the programmatic stack is accelerating and that vertical DSPs must secure differentiated supply relationships to compete with horizontal platforms.

On the demand side, Vistar has been actively building audience partnerships that complement DeepIntent's healthcare focus. Vistar's partnership page with T-Mobile details how advertisers can use app-ownership segments for competitive conquesting, in-market targeting, and behavioral DOOH campaigns, including use cases in retail, travel, entertainment, and quick-service restaurants. While none of those verticals are pharma-specific, the underlying data infrastructure, which connects mobile behaviors to real-world screen placements, is directly applicable to DeepIntent's patient-audience model. The integration allows pharmaceutical marketers to layer condition-based and prescriber-behavior segments on top of Vistar's location-verified impression counts, creating a measurement framework that bridges the gap between digital precision and physical-world reach that has historically kept pharma budgets away from DOOH.